glp-1 ibd A schematic representation of the mechanism of glucagon-like peptide-1 Role of glucagon-like peptides in

GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.

1 month supply

Understanding biomarkers, genetic predispositions, and individualized medical evaluation can support informed conversations with providers

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.